Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia

NCT07657793 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

164

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus
Immune Thrombocytopenia

Interventions

DRUG: Sirolimus
DRUG: Placebo

Sponsor

Chinese SLE Treatment And Research Group